Aspirin use in older patients with heart failure and coronary artery disease: National prescription patterns and relationship with outcomes

Journal of the American College of Cardiology

Volumn 46, Issue 6, 2005, Pages 955-962

  Masoudi, Frederick A ^a,b,c   Wolfe, Pam ^c   Havranek, Edward P ^a,b,c   Rathore, Saif S ^d   Foody, Joanne M ^d   Krumholz, Harlan M ^c,d,e  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Colorado Foundation for Medical Care ^*  (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; MULTIVARIATE ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERIOSCLEROSIS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PRESCRIPTIONS, DRUG; TREATMENT OUTCOME;

EID: 24944445157     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.062     Document Type: Article

References (44)

1. T.J. Ryan, E.M. Antman, N.H. Brooks 1999 update ACC/AHA guidelines for the management of patients with acute myocardial infarction J Am Coll Cardiol 34 1999 890 911
2. E. Braunwald, E.M. Antman, J.W. Beasley ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction J Am Coll Cardiol 36 2000 970 1062
3. S.C. Smith Jr., J.T. Dove, A.K. Jacobs ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - executive summary Circulation 103 2001 3019 3041
4. R.J. Gibbons, K. Chatterjee, J. Daley ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina J Am Coll Cardiol 33 1999 2092 2197
5. D. Hall, H. Zeitler, W. Rudolph Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure J Am Coll Cardiol 20 1992 1549 1555
6. R.P. Kimberly, P.H. Plotz Aspirin-induced depression of renal function N Engl J Med 296 1977 418 424
7. R.S. Muther, D.M. Potter, W.M. Bennett Aspirin-induced depression of glomerular filtration rate in normal humans role of sodium balance Ann Intern Med 94 1981 317 321
8. P.P. Koopmans, T. Thien, F.W. Gribnau Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension Br Med J Clin Res Ed 289 1984 1492 1494
9. K.N. Nguyen, I. Aursnes, J. Kjekshus Interaction between enalapril and aspirin on mortality after acute myocardial infarction subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) Am J Cardiol 79 1997 115 119
10. A.S. Al-Khadra, D.N. Salem, W.M. Rand, J.E. Udelson, J.J. Smith, M.A. Konstam Antiplatelet agents and survival a cohort analysis from the Studies Of Left Ventricular Dysfunction (SOLVD) trial J Am Coll Cardiol 31 1998 419 425
11. M. Oosterga, R.L. Anthonio, P.J. De Kam, J.H. Kingma, H.J. Crijns, W.H. Van Gilst Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction Am J Cardiol 81 1998 1178 1181
12. J.G. Peterson, E.J. Topol, S.K. Sapp, J.B. Young, A.M. Lincoff, M.S. Lauer Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease Am J Med 109 2000 371 377
13. R. Latini, E. Santoro, S. Masson Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction results of the GISSI-3 trial Heart Disease 2 2000 185 190
14. K.K. Teo, S. Yusuf, M. Pfeffer Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin a systematic review Lancet 360 2002 1037 1043
15. H.M. Krumholz, Y.T. Chen, M.J. Radford Aspirin and the treatment of heart failure in the elderly Arch Intern Med 161 2001 577 582
16. K.J. Harjai, S. Solis, A. Prasad, J. Loupe Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure Int J Cardiol 88 2003 207 214
17. V. Aumegeat, N. Lamblin, P. de Groote Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with angiotensin-converting enzyme inhibitors Chest 124 2003 1250 1258
18. M. Guazzi, R. Brambilla, G. Reina, G. Tumminello, M.D. Guazzi Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure a dose-related adverse effect of aspirin Arch Intern Med 163 2003 1574 1579
19. H.M. Krumholz, M.J. Radford, E.F. Ellerbeck Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes Circulation 92 1995 2841 2847
20. H.M. Krumholz, M.J. Radford, E.F. Ellerbeck Aspirin for secondary prevention after acute myocardial infarction in the elderly prescribed use and outcomes Ann Intern Med 124 1996 292 298
21. T.A. Marciniak, E.F. Ellerbeck, M.J. Radford Improving the quality of care for Medicare patients with acute myocardial infarction results from the Cooperative Cardiovascular Project JAMA 279 1998 1351 1357
22. S.F. Jencks, T. Cuerdon, D.R. Burwen Quality of medical care delivered to Medicare beneficiaries a profile at state and national levels JAMA 284 2000 1670 1676
23. S.F. Jencks, E.D. Huff, T. Cuerdon Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001 JAMA 289 2003 305 312
24. S.A. Hunt, D.W. Baker, M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult executive summary J Am Coll Cardiol 38 2001 2101 2113
25. E.P. Havranek, F.A. Masoudi, K.A. Westfall, P. Wolfe, D.L. Ordin, H.M. Krumholz Spectrum of heart failure in older patients results from the National Heart Failure project Am Heart J 143 2002 412 417
26. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
27. K. Kenward The scope of the data available in the AMA's Physician Masterfile Am J Public Health 86 1996 1481 1482
28. L.M. Baldwin, W. Adamache, C.N. Klabunde, K. Kenward, C. Dahlman, L. Warren Linking physician characteristics and Medicare claims data issues in data availability, quality, and measurement Med Care 40 Suppl 8 2002 IV82 IV95
29. L.I. Iezzoni Risk Adjustment for Measuring Health Care Outcomes 2nd edition 1997 Health Administration Press Chicago, IL
30. American Hospital Association The AHA Annual Survey Database Fiscal Year 1998 Documentation 1999 Health Forum, AHA Chicago, IL
31. American Hospital Association The AHA Annual Survey Database Fiscal Year 2000 Documentation 2001 Health Forum, AHA Chicago, IL
32. C. Fleming, E.S. Fisher, C.H. Chang, T.A. Bubolz, D.J. Malenka Studying outcomes and hospital utilization in the elderly. The advantages of a merged data base for Medicare and Veterans Affairs hospitals Med Care 30 1992 377 391
33. H. Goldstein Multilevel Statistical Models 2nd edition 1999 Institute of Education, Multilevel Models Project London
34. J. Zhang, K.F. Yu What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes JAMA 280 1998 1690 1691
35. J.R. Teerlink, B.M. Massie The interaction of ACE inhibitors and aspirin in heart failure torn between two lovers Am Heart J 138 1999 193 197
36. D. Hall Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure? Cardiol Clin 19 2001 597 603
37. J.G. Cleland, F. Alamgir, N.P. Nikitin, A.L. Clark, M. Norell What is the optimal medical management of ischemic heart failure? Prog Cardiovasc Dis 43 2001 433 455
38. M.A. Konstam Aspirin and heart failure square evidence meets a round patient Congest Heart Fail 9 2003 203 205
39. American Heart Association Heart and Stroke Statistics - 2003 Update 2002 American Heart Association Dallas, TX
40. J.G. Cleland, K. Thygesen, B.F. Uretsky Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study Eur Heart J 22 2001 1601 1612
41. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 J Am Coll Cardiol 12 1988 3A 13A
42. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
43. J.A. Cairns, M. Gent, J. Singer Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial N Engl J Med 313 1985 1369 1375
44. H.D. Lewis Jr., J.W. Davis, D.G. Archibald Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study N Engl J Med 309 1983 396 403